Clinical characteristics and outcomes in critical patients with hemorrhagic fever with renal syndrome

BMC Infectious Diseases

Volumn 14, Issue 1, 2014, Pages

  Du, Hong ^a   Wang, Ping Zhong ^a   Li, Jing ^a   Bai, Lu ^b   Li, Huan ^a   Yu, Hai Tao ^a   Jiang, Wei ^a   Zhang, Ye ^a   Wang, Jun Ning ^a   Bai, Xue Fan ^a  

^a FOURTH MILITARY MEDICAL UNIVERSITY   (China)

^b FOURTH MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Hantavirus; Hemorrhagic fever with renal syndrome; Prognosis

Indexed keywords

ALANINE AMINOTRANSFERASE; CREATININE; GLUCOSE; HEMOGLOBIN;

ADULT; ADULT RESPIRATORY DISTRESS SYNDROME; AGITATION; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALBUMIN BLOOD LEVEL; ARTICLE; BACTEREMIA; BRAIN DISEASE; CLINICAL FEATURE; COMA; CONJUNCTIVAL HEMORRHAGE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; CRITICALLY ILL PATIENT; DYSPNEA; FEMALE; GASTROINTESTINAL HEMORRHAGE; GLUCOSE BLOOD LEVEL; HEART ARRHYTHMIA; HEART FAILURE; HEMOGLOBIN BLOOD LEVEL; HEMORRHAGIC FEVER WITH RENAL SYNDROME; HUMAN; HYPERGLYCEMIA; HYPERTENSION; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; MORTALITY; OUTCOME ASSESSMENT; PARTIAL THROMBOPLASTIN TIME; PNEUMONIA; PROGNOSIS; PROTHROMBIN TIME; RETROSPECTIVE STUDY; RISK FACTOR; SURVIVAL RATE; THROMBIN TIME; THROMBOCYTE; UREA NITROGEN BLOOD LEVEL; AGED; COMPLICATION; EVALUATION STUDY; KAPLAN MEIER METHOD; MIDDLE AGED; RECEIVER OPERATING CHARACTERISTIC; STATISTICAL MODEL;

ADULT; AGED; FEMALE; HEMORRHAGIC FEVER WITH RENAL SYNDROME; HUMANS; KAPLAN-MEIER ESTIMATE; LOGISTIC MODELS; MALE; MIDDLE AGED; PROGNOSIS; RETROSPECTIVE STUDIES; RISK FACTORS; ROC CURVE; SURVIVAL RATE;

EID: 84900420503     PISSN: None     EISSN: 14712334     Source Type: Journal    
DOI: 10.1186/1471-2334-14-191     Document Type: Article

References (32)

1. Schmaljohn CS, Hasty SE, Dalrymple JM, LeDuc JW, Lee HW, von Bonsdorff CH, Brummer-Korvenkontio M, Vaheri A, Tsai TF, Regnery HL, Goldgaber D, Lee PW. Antigenic and genetic properties of viruses linked to hemorrhagic fever with renal syndrome. Science 1985, 227(4690):1041-1044. 10.1126/science.2858126, 2858126.
2. Muranyi W, Bahr U, Zeier M, van der Woude FJ. Hantavirus infection. J Am Soc Nephrol 2005, 16(12):3669-3679. 10.1681/ASN.2005050561, 16267154.
3. Schmaljohn C, Hjelle B. Hantaviruses: a global disease problem. Emerg Infect Dis 1997, 3(2):95-104. 10.3201/eid0302.970202, 2627612, 9204290.
4. Song G. Manual for Prevention and Cure of Hemorrhagic Fever with Renal Syndrome 1998, Beijing: People's Health Press.
5. Luo CW, Chen HX. Epidemiological characteristics and the strategy of vaccination on hemorrhagic fever with renal syndrome in the last 10 years, in China. Zhonghua Liu Xing Bing Xue Za Zhi 2008, 29(10):1017-1019.
6. Ma C, Yu P, Nawaz M, Zuo S, Jin T, Li Y, Li J, Li H, Xu J. Hantaviruses in rodents and humans, Xi'an. PR China. J Gen Virol 2012, 93(Pt 10):2227-2236.
7. Liu YX, Feng D, Zhang Q, Jia N, Zhao ZT, De Vlas SJ, Li J, Zhang PH, Yang H, Min JS, Feng PT, Ma SB, Cao WC. Key differentiating features between scrub typhus and hemorrhagic fever with renal syndrome in northern China. Am J Trop Med Hyg 2007, 76(5):801-805.
8. Rigau-Perez JG, Clark GG, Gubler DJ, Reiter P, Sanders EJ, Vorndam AV. Dengue and dengue hemorrhagic fever. Lancet 1998, 352(9132):971-977. 10.1016/S0140-6736(97)12483-7, 9752834.
9. Gregson A, Edelman R. Dengue virus infection. Pediatr Infect Dis J 2003, 22(2):179-181.
10. Welzel TM, Zeier M, Darai G, Ritz E. Hantavirus infection-new threats by an old virus. Nephrol Dial Transplant 1998, 13(11):2731-2733. 10.1093/ndt/13.11.2731, 9829468.
11. Lee JS. Clinical features of hemorrhagic fever with renal syndrome in Korea. Kidney Int Suppl 1991, 35:S88-93.
12. Bruno P, Hassell LH, Brown J, Tanner W, Lau A. The protean manifestations of hemorrhagic fever with renal syndrome: a retrospective review of 26 cases from Korea. Ann Intern Med 1990, 113(5):385-391. 10.7326/0003-4819-113-5-385, 1974404.
13. Gavrilovskaya IN, Brown EJ, Ginsberg MH, Mackow ER. Cellular entry of hantaviruses which cause hemorrhagic fever with renal syndrome is mediated by β3 integrins. J Virol 1999, 73(5):3951-3959. 104173, 10196290.
14. Hayasaka D, Maeda K, Ennis FA, Terajima M. Increased permeability of human endothelial cell line EA.hy926 induced by hantavirus-specific cytotoxic T lymphocytes. Virus Res 2007, 123(2):120-127. 10.1016/j.virusres.2006.08.006, 16979772.
15. Bai XF, Xu ZK. Hemorrhagic Fever with Renal Syndrome 2013, Beijing: People's Medical Publishing House.
16. Mehta RL, Kellum JA, Shah SV, Molitoris BA, Ronco C, Warnock DG, Levin A. Acute Kidney Injury Network: report of an initiative to improve outcomes in acute kidney injury. Critical Care 2007, 11(2):R31. 10.1186/cc5713, 2206446, 17331245.
17. Chinese Medical Association to severe medicine branch Guidelines for the Diagnosis and Treatment of Acute Lung Injury/Acute Respiratory Distress Syndrome (2006). 2011, http://www.csccm.org/cn/news.asp?id=115.html, Chinese Medical Association to severe medicine branch.
18. Chen WC. Possible interventional therapies in severe sepsis or septic shock. Acta Anaesthesiol Taiwan 2012, 50(2):74-77. 10.1016/j.aat.2012.05.003, 22769862.
19. Liu DV. Practical Critical Care Medicine 2010, Beijing: People's Medical Publishing House.
20. Hochstadt A, Meroz Y, Landesberg G. Myocardial dysfunction in severe sepsis and septic shock: more questions than answers?. J Cardiothorac Vasc Anesth 2011, 25(3):526-535. 10.1053/j.jvca.2010.11.026, 21296000.
21. Plyusnin A, Morzunov SP. Virus evolution and genetic diversity of hantaviruses and their rodent hosts. Curr Top Microbiol Immunol 2001, 256:47-75.
22. Ghahramani N, Shadrou S, Hollenbeak C. A systematic review of continuous renal replacement therapy and intermittent haemodialysis in management of patients with acute renal failure. Nephrology (Carlton) 2008, 13(7):570-578. 10.1111/j.1440-1797.2008.00966.x, 18518933.
23. Swartz RD, Bustami RT, Daley JM, Gillespie BW, Port FK. Estimating the impact of renal replacement therapy choice on outcome in severe acute renal failure. Clin Nephrol 2005, 63(5):335-345. 10.5414/CNP63335, 15909592.
24. Kim S, Sung SH, An HR, Jun YH, Yu M, Ryu DR, Kim SJ, Kang DH, Choi KB. A case report of crescentic glomerulonephritis associated with hantaan virus infection. Nephrol Dial Transplant 2010, 25(8):2790-2792. 10.1093/ndt/gfq253, 20466689.
25. Parkash O, Almas A, Jafri SM, Hamid S, Akhtar J, Alishah H. Severity of acute hepatitis and its outcome in patients with dengue fever in a tertiary care hospital Karachi, Pakistan (South Asia). BMC Gastroenterol 2010, 10:43. 10.1186/1471-230X-10-43, 2881113, 20459677.
26. Levi M, Löwenberg EC. Thrombocytopenia in critically ill patients. Semin Thromb Hemost 2008, 34(5):417-424. 10.1055/s-0028-1092871, 18956281.
27. Rasche FM, Uhel B, Kruger DH, Karges W, Czock D, Hampl W, Keller F, Meisel H, von Muller L. Thrombocytopenia and acute renal failure in Puumala hantavirus infections. Emerg Infect Dis 2004, 10(8):1420-1425. 10.3201/eid1008.031069, 3320406, 15496243.
28. Vanderschueren S, De Weerdt A, Malbrain M, Vankersschaever D, Frans E, Wilmer A, Bobbaers H. Thrombocytopenia and prognosis in intensive care. Crit Care Med 2000, 28(6):1871-1876. 10.1097/00003246-200006000-00031, 10890635.
29. Guzman MG, Kouri G. Dengue: an update. Lancet Infect Dis 2002, 2(1):33-42. 10.1016/S1473-3099(01)00171-2, 11892494.
30. Huang YH, Liu CC, Wang ST, Lei HY, Liu HL, Lin YS, Wu HL, Yeh TM. Activation of coagulation and fibrinolysis during dengue virus infection. J Med Virol 2001, 63(3):247-251. 10.1002/1096-9071(200103)63:3<247::AID-JMV1008>3.0.CO;2-F, 11170065.
31. Chua MN, Molanida R, de Guzman M, Laberiza F. Prothrombin time and partial thromboplastin time as a predictor of bleeding in patients with dengue hemorrhagic fever. Southeast Asian J Trop Med Public Health 1993, 24(Suppl 1):141-143.
32. Lee IK, Liu JW, Yang KD. Clinical characteristics, risk factors, and outcomes in adults experiencing dengue hemorrhagic fever complicated with acute renal failure. Am J Trop Med Hyg 2009, 80(4):651-655.